GlassScriptPhysician profile
Jasmine Cobb
NPI 1518518323
$2,803.84
in general payments reported to CMS, 2019-2025
12 companies · $1,468 in 2025
The $1,468 reported for 2025 was more than what 92% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $43.41 · 2023: $561 · 2024: $731 · 2025: $1,468.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,399 · Travel and Lodging: $254 · Education: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,398.50 |
| Travel and Lodging | $253.93 |
| Education | $108.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,084.65 | 2022-2025 | Relistor |
| Medtronic, INC. | $897.82 | 2025 | Synchromedii |
| Collegium Pharmaceutical, INC. | $296.50 | 2022-2025 | Belbuca, Xtampza |
| Valinor Pharma, LLC | $261.73 | 2023-2025 | Movantik |
| Abbott Laboratories | $74.61 | 2023-2025 | Octrode, Proclaim, Eterna |
| Appliedvr INC | $47.11 | 2025 | Relievrx |
| Averitas Pharma INC. | $42.92 | 2024 | Qutenza |
| Foundation Fusion Solutions, LLC | $26.76 | 2024 | |
| Boston Scientific Corporation | $20.40 | 2025 | Wavewriter Alpha Prime 16 |
| Vertex Pharmaceuticals Incorporated | $19.11 | 2024 | |
| Grt US Holding, INC. | $19.11 | 2022 | |
| Nalu Medical, INC. | $13.12 | 2023 | Nalu Neurostimulation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jasmine Cobb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.